{"id":410470,"date":"2026-09-25T16:32:11","date_gmt":"2026-09-25T16:32:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-fl\/410470\/"},"modified":"2026-09-25T16:32:11","modified_gmt":"2026-09-25T16:32:11","slug":"openevidence-hits-15b-valuation-as-its-ambitions-move-far-beyond-medical-search","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-fl\/410470\/","title":{"rendered":"OpenEvidence hits $15B valuation as its ambitions move far beyond medical search"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.openevidence.com\/\" target=\"_blank\" rel=\"noopener nofollow\">OpenEvidence<\/a> started with a relatively straightforward pitch: give doctors a better way to find answers buried across a vast body of medical research.<\/p>\n<p class=\"wp-block-paragraph\">Four years later, the Miami-based company is worth $15 billion, has raised more than $1 billion over the past year, is working with one of the world\u2019s leading cancer centers and Anthropic, and is preparing to do something far more ambitious than answer doctors\u2019 questions: develop cancer drugs of its own.<\/p>\n<p class=\"wp-block-paragraph\">The latest sign of OpenEvidence\u2019s rapid expansion came with a new $250 million funding round led by hospital systems and Andreessen Horowitz, according to <a href=\"https:\/\/www.businessinsider.com\/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9\" target=\"_blank\" rel=\"noopener nofollow\">Business Insider<\/a>. The deal valued the company at $15 billion, up from the $12 billion valuation it secured in another <a href=\"https:\/\/refreshmiami.com\/news\/openevidence-lands-250m-to-further-develop-the-ai-doctors-already-rely-on\/\" rel=\"nofollow noopener\" target=\"_blank\">$250 million round in January<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">That makes the fundraising cadence almost as notable as the number itself. OpenEvidence has now raised more than $1 billion over the past year from a roster that includes Thrive Capital, DST, GV, Kleiner Perkins, Sequoia Capital, and Nvidia..<\/p>\n<p class=\"wp-block-paragraph\">But the bigger story may be what OpenEvidence plans to do with its growing war chest.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/www.newsbeep.com\/us-fl\/wp-content\/uploads\/2026\/09\/1712501845379.jpg\" alt=\"\" class=\"wp-image-233434\" style=\"width:179px;height:auto\"  \/><\/p>\n<p class=\"wp-block-paragraph\">Founded in 2022 by Daniel Nadler (pictured left) and Zachary Ziegler, OpenEvidence built an AI-powered clinical search platform designed to help physicians quickly find and interpret medical evidence. The company has described it as \u201cthe fastest-growing application for physicians in history.\u201d\u00a0<\/p>\n<p class=\"wp-block-paragraph\">Now, it is pushing deeper into oncology.<\/p>\n<p class=\"wp-block-paragraph\">OpenEvidence recently struck a partnership with Memorial Sloan Kettering Cancer Center that will integrate its technology directly into MSK\u2019s Epic workflow. At the same time, MSK\u2019s OncoKB precision oncology knowledge base will be incorporated into OpenEvidence, giving physicians outside the cancer center access to its expert interpretation of cancer-related genetic alterations.<\/p>\n<p>\u2713<\/p>\n<p>            Check your inbox for a confirmation email.<\/p>\n<p class=\"wp-block-paragraph\">The idea is to make highly specialized cancer knowledge available at the moment doctors are making treatment decisions.<\/p>\n<p class=\"wp-block-paragraph\">\u201cPrecision oncology has produced an extraordinary amount of knowledge, but that knowledge only helps a patient if the right interpretation reaches the physician at the moment a decision is being made,\u201d OpenEvidence Chief Medical Officer Travis Zack said in the <a href=\"https:\/\/www.openevidence.com\/announcements\/memorial-sloan-kettering-cancer-center-msk-and-openevidence-partner-to-advance-precision-oncology-at-the-point-of-care\" target=\"_blank\" rel=\"noopener nofollow\">announcement<\/a> last week.<\/p>\n<p class=\"wp-block-paragraph\">OpenEvidence\u2019s plans go further still. Nadler told Forbes that the company intends to use data from its MSK relationship, along with information from an earlier agreement with the National Comprehensive Cancer Network, to build its own pipeline of potential therapies. He said OpenEvidence expected to get its first drug into clinical trials before the end of 2026, followed by another three to five potential therapies next year, with rare cancers among its initial areas of focus.<\/p>\n<p class=\"wp-block-paragraph\">That would mark a striking shift for a company best known as something of a \u201cChatGPT for doctors.\u201d OpenEvidence would effectively be moving from helping physicians understand existing medicine toward trying to create new medicine itself.<\/p>\n<p class=\"wp-block-paragraph\">The expansion comes as competition in healthcare AI is heating up. OpenAI, Anthropic, and other major AI companies have been pushing further into healthcare, while specialized companies are building products across clinical documentation, medical search, and other physician workflows.<\/p>\n<p class=\"wp-block-paragraph\">OpenEvidence is working with some of those potential competitors rather than keeping them at arm\u2019s length. This week, it announced a partnership with Anthropic to provide AI-powered clinical decision support to physicians in nearly 100 low- and middle-income countries.<\/p>\n<p class=\"wp-block-paragraph\">\u201cAccess to medical knowledge shouldn\u2019t depend on geography,\u201d Nadler <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/anthropic-openevidence-partner-bring-medical-ai-worldwide-2026-09-22\/\" target=\"_blank\" rel=\"noopener nofollow\">said<\/a> of the partnership.<\/p>\n<p class=\"wp-block-paragraph\">READ MORE IN REFRESH MIAMI:<\/p>\n<p>                         <a href=\"https:\/\/refreshmiami.com\/author\/rileykaminer\/\" class=\"url\" title=\"Riley Kaminer\" rel=\"nofollow noopener\" target=\"_blank\"> <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/us-fl\/wp-content\/uploads\/2026\/09\/1790353931_37_4q0a7418-1.jpeg\" class=\"photo\" width=\"250\" alt=\"Riley Kaminer\"\/><\/a> <\/p>\n<p>I am a Miami-based technology researcher and writer with a passion for sharing stories about the South Florida tech ecosystem. I particularly enjoy learning about GovTech startups, cutting-edge applications of artificial intelligence, and innovators that leverage technology to transform society for the better. Always open for pitches via Twitter @rileywk or www.RileyKaminer.com.<\/p>\n<p> <a href=\"https:\/\/refreshmiami.com\/author\/rileykaminer\/\" class=\"url\" title=\"Riley Kaminer\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/us-fl\/wp-content\/uploads\/2026\/09\/1790353931_37_4q0a7418-1.jpeg\" class=\"photo\" width=\"250\" alt=\"Riley Kaminer\"\/><\/a>Latest posts by Riley Kaminer (<a href=\"https:\/\/refreshmiami.com\/author\/rileykaminer\/\" rel=\"nofollow noopener\" target=\"_blank\">see all<\/a>)  \t<\/p>\n","protected":false},"excerpt":{"rendered":"OpenEvidence started with a relatively straightforward pitch: give doctors a better way to find answers buried across a&hellip;\n","protected":false},"author":2,"featured_media":410471,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[225,227,226],"class_list":["post-410470","post","type-post","status-publish","format-standard","has-post-thumbnail","category-hialeah","tag-hialeah","tag-hialeah-headlines","tag-hialeah-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/410470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/comments?post=410470"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/410470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media\/410471"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media?parent=410470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/categories?post=410470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/tags?post=410470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}